{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:02:51Z","timestamp":1784289771418,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hebei Province Finance Department Project","award":["ZF2024133"],"award-info":[{"award-number":["ZF2024133"]}]},{"name":"S&T Program of Hebei","award":["22377719D"],"award-info":[{"award-number":["22377719D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51659-9","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:04:02Z","timestamp":1779098642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tanshinone IIA inhibits foam cell formation and alleviates atherosclerosis by regulating the Hedgehog signaling pathway through TRPM2 suppression"],"prefix":"10.1038","volume":"16","author":[{"given":"Yajuan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"51659_CR1","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk, E. Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 47, C7\u201312 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"51659_CR2","first-page":"7441","volume":"11","author":"R Zeng","year":"2019","unstructured":"Zeng, R., Song, X. J., Liu, C. W. & Ye, W. LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway. Am. J. Transl Res. 11, 7441\u20137448 (2019).","journal-title":"Am. J. Transl Res."},{"key":"51659_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/pin.13202","volume":"72","author":"J Fan","year":"2022","unstructured":"Fan, J., Watanabe, T. & Atherosclerosis Known and unknown. Pathol. Int. 72, 151\u2013160 (2022).","journal-title":"Pathol. Int."},{"key":"51659_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","volume":"40","author":"TJ Barrett","year":"2020","unstructured":"Barrett, T. J. Macrophages in atherosclerosis regression. Arterioscler. Thromb. Vasc Biol. 40, 20\u201333 (2020).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"51659_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1152\/physiolgenomics.00051.2006","volume":"29","author":"HJ Cho","year":"2007","unstructured":"Cho, H. J. et al. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol. Genomics. 29, 149\u2013160 (2007).","journal-title":"Physiol. Genomics"},{"key":"51659_CR6","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1161\/CIRCRESAHA.123.323156","volume":"134","author":"C Ma","year":"2024","unstructured":"Ma, C. et al. Gs\u03b1 Regulates macrophage foam cell formation during atherosclerosis. Circ. Res. 134, e34\u2013e51 (2024).","journal-title":"Circ. Res."},{"key":"51659_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/cvr\/cvu213","volume":"104","author":"K Szilagyi","year":"2014","unstructured":"Szilagyi, K. et al. PKC\u03b4 is dispensible for oxLDL uptake and foam cell formation by human and murine macrophages. Cardiovasc. Res. 104, 467\u2013476 (2014).","journal-title":"Cardiovasc. Res."},{"key":"51659_CR8","doi-asserted-by":"crossref","unstructured":"L, C. S. et al. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans. Human immunology 75, (2014).","DOI":"10.1016\/j.humimm.2014.01.012"},{"key":"51659_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2018.10.004","volume":"195","author":"A Liu","year":"2019","unstructured":"Liu, A. et al. Statins: Adverse reactions, oxidative stress and metabolic interactions. Pharmacol. Ther. 195, 54\u201384 (2019).","journal-title":"Pharmacol. Ther."},{"key":"51659_CR10","first-page":"2931","volume":"16","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer. Exp. Ther. Med. 16, 2931\u20132937 (2018).","journal-title":"Exp. Ther. Med."},{"key":"51659_CR11","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.2147\/DDDT.S266911","volume":"14","author":"R Guo","year":"2020","unstructured":"Guo, R. et al. Pharmacological activity and mechanism of Tanshinone IIA in related diseases. DDDT 14, 4735\u20134748 (2020).","journal-title":"DDDT"},{"key":"51659_CR12","doi-asserted-by":"publisher","first-page":"105364","DOI":"10.1016\/j.phrs.2020.105364","volume":"164","author":"MA Ansari","year":"2021","unstructured":"Ansari, M. A. et al. Prospective therapeutic potential of Tanshinone IIA: An updated overview. Pharmacol. Res. 164, 105364 (2021).","journal-title":"Pharmacol. Res."},{"key":"51659_CR13","doi-asserted-by":"crossref","unstructured":"Zong, P., Feng, J., Yue, Z., Yue, L. & Abstract 228: Trpm2 deficiency in macrophages protects mice against atherosclerosis. Arteriosclerosis Thromb. Vasc. Biol. 42, (2022).","DOI":"10.1161\/atvb.42.suppl_1.228"},{"key":"51659_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/ajh\/hpaa154","volume":"34","author":"Y Dai","year":"2021","unstructured":"Dai, Y., Yan, X., Lin, Y., Chen, H. & Liu, X. Transient Receptor Potential Melastatin 2 enhances vascular reactivity during development of atherosclerosis in mice. Am. J. Hypertens. 34, 121\u2013122 (2021).","journal-title":"Am. J. Hypertens."},{"key":"51659_CR15","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.3390\/ijms22147635","volume":"22","author":"W Zieli\u0144ska","year":"2021","unstructured":"Zieli\u0144ska, W., Zabrzy\u0144ski, J., Gagat, M. & Grzanka, A. The role of TRPM2 in endothelial function and dysfunction. Int. J. Mol. Sci. 22, 7635 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"51659_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrm3598","volume":"14","author":"J Briscoe","year":"2013","unstructured":"Briscoe, J. & Th\u00e9rond, P. P. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat. Rev. Mol. Cell. Biol. 14, 416\u2013429 (2013).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"51659_CR17","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41419-023-06270-5","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosis. Cell. Death Dis. 14, 740 (2023).","journal-title":"Cell. Death Dis."},{"key":"51659_CR18","doi-asserted-by":"crossref","unstructured":"Yu, A., Yue, Z., Feng, J., Aguila, H. & Yue, L. Abstract 17182: The role of ROS sensitive TRPM2 mediated inflammation in atherosclerosis. Circulation 138, (2018).","DOI":"10.1161\/circ.138.suppl_1.17182"},{"key":"51659_CR19","doi-asserted-by":"crossref","unstructured":"Chen, L. et al. Platelet membrane-coated nanocarriers targeting plaques to deliver anti-CD47 antibody for atherosclerotic therapy. Research (Wash D C) 9845459 (2022).","DOI":"10.34133\/2022\/9845459"},{"key":"51659_CR20","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.2174\/1381612823666170822101112","volume":"23","author":"W Chen","year":"2018","unstructured":"Chen, W. & Chen, G. Danshen (Salvia miltiorrhiza Bunge): A prospective healing sage for cardiovascular diseases. Curr. Pharm. Design. 23, 5125\u20135135 (2018).","journal-title":"Curr. Pharm. Design"},{"key":"51659_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/kjm2.12663","volume":"39","author":"W Li","year":"2023","unstructured":"Li, W., Gao, Z. & Guan, Q. L. Tan IIA mitigates vascular smooth muscle cell proliferation and migration induced by ox-LDL through the miR-137\/TRPC3 axis. Kaohsiung J. Med. Sci. 39, 596\u2013604 (2023).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"51659_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jep.2014.07.010","volume":"155","author":"M F","year":"2014","unstructured":"F, M. et al. Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via Erk-2 signaling pathway. J. Ethnopharmacol. 155, 1236\u20131242 (2014).","journal-title":"J. Ethnopharmacol."},{"key":"51659_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/med.21438","volume":"38","author":"J Fang","year":"2018","unstructured":"Fang, J., Little, P. J. & Xu, S. Atheroprotective effects and molecular targets of tanshinones derived from herbal medicine Danshen. Med. Res. Rev. 38, 201\u2013228 (2018).","journal-title":"Med. Res. Rev."},{"key":"51659_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1476-511X-13-111","volume":"13","author":"O Gruzdeva","year":"2014","unstructured":"Gruzdeva, O. et al. Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction. Lipids Health Dis. 13, 111 (2014).","journal-title":"Lipids Health Dis."},{"key":"51659_CR25","doi-asserted-by":"publisher","first-page":"159533","DOI":"10.1016\/j.bbalip.2024.159533","volume":"1869","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. Ilexgenin A inhibits lipid accumulation in macrophages and reduces the progression of atherosclerosis through PTPN2\/ERK1\/2\/ABCA1 signalling pathway. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1869, 159533 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"51659_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12953-021-00183-x","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. TMT-based quantitative proteomic profiling of human monocyte-derived macrophages and foam cells. Proteome Sci. 20, 1 (2022).","journal-title":"Proteome Sci."},{"key":"51659_CR27","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/ijms22041593","volume":"22","author":"L Jacobo-Albavera","year":"2021","unstructured":"Jacobo-Albavera, L., Dom\u00ednguez-P\u00e9rez, M., Medina-Leyte, D. J., Gonz\u00e1lez-Garrido, A. & Villarreal-Molina, T. The role of the ATP-Binding Cassette A1 (ABCA1) in human disease. Int. J. Mol. Sci. 22, 1593 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"51659_CR28","doi-asserted-by":"publisher","unstructured":"Fayyad-Kazan, M., Awada, R., Fayyad-Kazan, H. & Soayfane, Z. Glucose depletion reduces cholesterol intracellular accumulation in ABCB1-dependent mechanism. Nucleosides Nucleotides Nucleic Acids. 1\u201316 https:\/\/doi.org\/10.1080\/15257770.2025.2473436 (2025).","DOI":"10.1080\/15257770.2025.2473436"},{"key":"51659_CR29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1161\/CIRCRESAHA.117.311747","volume":"121","author":"M Mittal","year":"2017","unstructured":"Mittal, M. et al. Neutrophil activation of endothelial cell-expressed TRPM2 mediates transendothelial neutrophil migration and vascular injury. Circ. Res. 121, 1081\u20131091 (2017).","journal-title":"Circ. Res."},{"key":"51659_CR30","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.3390\/ijms22147635","volume":"22","author":"W Zieli\u0144ska","year":"2021","unstructured":"Zieli\u0144ska, W., Zabrzy\u0144ski, J., Gagat, M. & Grzanka, A. The role of TRPM2 in endothelial function and dysfunction. Int. J. Mol. Sci. 22, 7635 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"51659_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/vaccines13030241","volume":"13","author":"F Ying","year":"2025","unstructured":"Ying, F. et al. Active immunization using TRPM2 peptide vaccine attenuates atherosclerotic progression in a mouse model of atherosclerosis. Vaccines (Basel). 13, 241 (2025).","journal-title":"Vaccines (Basel)"},{"key":"51659_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s44161-022-00027-7","volume":"1","author":"P Zong","year":"2022","unstructured":"Zong, P. et al. TRPM2 deficiency in mice protects against atherosclerosis by inhibiting TRPM2-CD36 inflammatory axis in macrophages. Nat. Cardiovasc. Res. 1, 344\u2013360 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"51659_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ydbio.2008.02.025","volume":"317","author":"AL Barrett","year":"2008","unstructured":"Barrett, A. L., Krueger, S. & Datta, S. Branchless and Hedgehog operate in a positive feedback loop to regulate the initiation of neuroblast division in the Drosophila larval brain. Dev. Biol. 317, 234\u2013245 (2008).","journal-title":"Dev. Biol."},{"key":"51659_CR34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/CIRCULATIONAHA.119.041059","volume":"140","author":"D Aravani","year":"2019","unstructured":"Aravani, D. et al. HHIPL1, a gene at the 14q32 coronary artery disease locus, positively regulates hedgehog signaling and promotes atherosclerosis. Circulation 140, 500\u2013513 (2019).","journal-title":"Circulation"},{"key":"51659_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/path.2193","volume":"212","author":"L Beckers","year":"2007","unstructured":"Beckers, L. et al. Disruption of hedgehog signalling in ApoE - \/- mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophages. J. Pathol. 212, 420\u2013428 (2007).","journal-title":"J. Pathol."},{"key":"51659_CR36","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1113\/jphysiol.2010.201855","volume":"589","author":"A Sumoza-Toledo","year":"2011","unstructured":"Sumoza-Toledo, A. & Penner, R. TRPM2: a multifunctional ion channel for calcium signalling. J. Physiol. 589, 1515\u20131525 (2011).","journal-title":"J. Physiol."},{"key":"51659_CR37","doi-asserted-by":"publisher","first-page":"114465","DOI":"10.1016\/j.intimp.2025.114465","volume":"152","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Wang, J., Yang, S., Kou, H. & Liu, P. Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs\/NF-\u03baB signaling pathway. Int. Immunopharmacol. 152, 114465 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"51659_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MCA.0000000000000835","volume":"31","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Tanshinone IIA protects mice against atherosclerotic injury by activating the TGF-\u03b2\/PI3K\/Akt\/eNOS pathway. Coron. Artery Dis. 31, 385 (2020).","journal-title":"Coron. Artery Dis."},{"key":"51659_CR39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/10428194.2018.1493727","volume":"60","author":"K Cai","year":"2019","unstructured":"Cai, K. et al. Targeting the cross-talk between the hedgehog and NF-\u03baB signaling pathways in multiple myeloma. Leuk. Lymphoma. 60, 772\u2013781 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"51659_CR40","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1182\/blood-2012-12-470153","volume":"121","author":"C Qu","year":"2013","unstructured":"Qu, C. et al. Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-\u03baB activation in diffuse large B-cell lymphoma. Blood 121, 4718\u20134728 (2013).","journal-title":"Blood"},{"key":"51659_CR41","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1158\/0008-5472.CAN-12-1248","volume":"72","author":"B Ramaswamy","year":"2012","unstructured":"Ramaswamy, B. et al. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K\/AKT pathway. Cancer Res. 72, 5048\u20135059 (2012).","journal-title":"Cancer Res."},{"key":"51659_CR42","first-page":"25","volume":"21","author":"L Yan","year":"2021","unstructured":"Yan, L. et al. Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE-\/- mice. Exp. Ther. Med. 21, 25 (2021).","journal-title":"Exp. Ther. Med."},{"key":"51659_CR43","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1111\/jcmm.18000","volume":"27","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4\/PPAR\u03b3 signalling. J. Cell. Mol. Med. 27, 4155\u20134170 (2023).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51659-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51659-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51659-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:03:21Z","timestamp":1784286201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51659-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51659"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51659-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the Ethics Committee of the First Hospital of Hebei Medical University (Approval No. 20200385).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22440"}}